Doxorubicin Hydrochloride Injection, Suspension, Liposomal
Product Images NDC 62332-810

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Doxorubicin Hydrochloride (NDC 62332-810). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Doxorubicin-10ml-carton (Doxorubicin 10ml Carton)

This text appears to be a pharmaceutical label for a medication called DOXOrubicin Hydrochloride Liposome Injection. It provides information on dosage, composition, dilution instructions, and storage requirements for this intravenous infusion medication. The manufacturer is identified as Alembic Pharmaceuticals. The label emphasizes the cytotoxic nature of the formulation and warns against substituting it with other medications. Instructions for discarding unused portions and using specific diluents are also included. Please consult with a healthcare professional for detailed guidance and proper administration of this medication.*

FDA Label Image

Doxorubicin-10ml-vial (Doxorubicin 10ml Vial)

The text describes a medication named DOXOrubicin Hydrochloride Liposome Injection with a concentration of 20 mg/1. It is indicated for intravenous infusion only after dilution and comes in a 10 mL single-dose vial. The recommended storage temperature is between 2° to 8°C (36° to 46°F), and it should not be frozen. The medication is manufactured for Alembic Pharmaceuticals, Inc. in Bedminster, NJ, USA, and it is made in India. The lot number and expiration date are not available in the provided text.*

FDA Label Image

Doxorubicin-25ml-carton (Doxorubicin 25ml Carton)

The document contains information related to Doxorubicin Hydrochloride Liposome Injection, including dosage, composition, manufacturing details, and instructions for use. It emphasizes the cytotoxic nature of the substance and the necessity of proper refrigeration. The formulation is in a liposomal form and is specifically for intravenous infusion after dilution. Careful attention to dosing and usage guidelines, as per the prescribing information, is advised.*

FDA Label Image

Oxorubicin-25ml-vial (Doxorubicin 25ml Vial)

This is a prescription information for Doxorubicin Hydrochloride Liposome Injection, a cytotoxic medication meant for intravenous infusion. It is advised to be diluted with 5% Dextrose Injection, USP before administration. The product should be stored refrigerated at 2° to 8°C and not frozen. The recommended dosage should be consulted based on the prescribing information provided in the package. The manufacturer is Alembic Pharmaceuticals in Bedminster, NJ, USA.*

FDA Label Image

Doxorubicin-figure-1 (Doxorubicin Figure 1)

This is a statistical table presenting results from a study comparing the combination of Doxorubicin HCI and Bortezomib with just Bortezomib alone. The table includes a p-value indicating the statistical significance, as well as the Hazard Ratio (HR) with its 95% Confidence Interval (CI). The data also shows the number of subjects at risk over time in months, with a visual indication of censored data points.*

FDA Label Image

Doxorubicin-hspe (Doxorubicin Hspe)

FDA Label Image

Doxorubicin-mpeg-dspe (Doxorubicin Mpeg Dspe)

FDA Label Image

Doxorubicin-pegylated-liposome (Doxorubicin Pegylated Liposome)

This text is talking about a coating called MPEG-DSPE which has an aqueous core entrapped with doxorubicin HCI and is enclosed by a liposomal bilayer. The coating may have applications in drug delivery or other areas requiring controlled release or targeted delivery.*

FDA Label Image

Doxorubicin-structure. (Doxorubicin Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.